Company / Profit Margin
10x Genomics, Inc. Profit Margin History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-6.8%
FY2025
5-year range
-181.6% / -6.8%
FY2021-FY2025
Trend
+77.4%
vs FY2024
Sector context
#115 of 156
Health Care
What the data says
At -6.8%, 10x Genomics, Inc.'s profit margin ranks #115 of 156 in the Health Care sector. Profit Margin has increased for 3 consecutive years, from -181.6% in FY2022 to -6.8% in FY2025.
Based on SEC 10-K filings.
-6.8% in FY2025 with a 5-year CAGR of +174.8%.
Improved from -41.2% to -6.8% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +174.8pp
- 5-Year Change
- +174.8pp
- 10-Year Change
- -
Sector benchmark
#115 of 156 in Health CareTop 74% of 156This company -6.8% Sector average -252.5%
▼
+97.3% above sector average
Key checks
Key Insights
- 10x Genomics, Inc.'s profit margin has grown for 3 consecutive years.
- In FY2025, profit margin increased 77.4% year-over-year.
- Currently 245.7pp above the Health Care sector average.
- Lowest profit margin in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -6.8% | +77.4% |
| FY2024 | -29.9% | +27.5% |
| FY2023 | -41.2% | +77.3% |
| FY2022 | -181.6% | -1328.9% |
| FY2021 | -12.7% | +93.0% |
| FY2020 | -181.6% | -211.3% |
| FY2019 | -58.3% | +24.1% |
| FY2018 | -76.9% | -191.3% |
| FY2017 | -26.4% | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026